Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of AK150 in Advanced Malignant Solid Tumor

NCT07566247 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT07566247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07566247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of AK150 in Advanced Malignant Solid Tumor
Lead sponsor
Akeso
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
June 7, 2029
Enrollment
96 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid tumors